• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.与非侵入性产前检测相关的伦理、法律和社会问题(ELSI):对产前诊断和生殖选择演变的思考。
Genes (Basel). 2021 Jan 30;12(2):204. doi: 10.3390/genes12020204.
2
Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.非侵入性产前检测(NIPT)的范围限制:对产前筛查国际伦理框架的分析及对荷兰专业人士的访谈研究。
BMC Pregnancy Childbirth. 2018 Oct 19;18(1):409. doi: 10.1186/s12884-018-2050-4.
3
Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.非侵入性产前检测引入的伦理挑战:来自黎巴嫩和魁北克的医疗保健专业人员观点的定性研究。
BMC Med Ethics. 2020 Feb 10;21(1):15. doi: 10.1186/s12910-020-0455-x.
4
Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.关于无创产前检测决策的跨文化视角:黎巴嫩和魁北克的比较研究。
AJOB Empir Bioeth. 2018 Apr-Jun;9(2):99-111. doi: 10.1080/23294515.2018.1469551.
5
Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.产科专业人士对非侵入性产前唐氏综合征筛查的看法:与现有检测方法相比的临床效用及伦理影响。
BMC Pregnancy Childbirth. 2017 Sep 5;17(1):285. doi: 10.1186/s12884-017-1474-6.
6
From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.从晚育到单基因疾病的产前筛查:证据和伦理问题。
Hum Reprod Update. 2021 Oct 18;27(6):1056-1085. doi: 10.1093/humupd/dmab023.
7
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
8
Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.无创产前基因检测:当前及新出现的伦理、法律和社会问题。
Annu Rev Genomics Hum Genet. 2015;16:369-98. doi: 10.1146/annurev-genom-090314-050000.
9
Prenatal screening: current practice, new developments, ethical challenges.产前筛查:当前实践、新进展与伦理挑战
Bioethics. 2015 Jan;29(1):1-8. doi: 10.1111/bioe.12123.
10
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.用于产前检测的母血血浆DNA和RNA测序
Adv Clin Chem. 2016;74:63-102. doi: 10.1016/bs.acc.2015.12.004. Epub 2016 Jan 21.

引用本文的文献

1
Healthcare professionals' perspectives on and experiences with non-invasive prenatal testing: a systematic review.医疗保健专业人员对无创产前检测的看法及体验:一项系统综述
Hum Genet. 2025 Apr;144(4):343-374. doi: 10.1007/s00439-025-02736-y. Epub 2025 Apr 9.
2
Towards a Responsible Implementation of NIPT as a First-Tier Test in Canada: Decision-Makers' Perspectives.在加拿大将无创产前检测(NIPT)作为一线检测进行负责任的实施:决策者的观点
Prenat Diagn. 2025 Apr;45(4):453-463. doi: 10.1002/pd.6753. Epub 2025 Jan 31.
3
Comparing the Introduction and Implementation of Noninvasive Prenatal Testing (NIPT) in Japan, the Netherlands, and the United States: An Integrative Review.日本、荷兰和美国无创产前检测(NIPT)的引入与实施比较:一项综合综述
Prenat Diagn. 2025 Jan 15. doi: 10.1002/pd.6708.
4
CffDNA screening for Niemann-pick disease, type C1: a case series.用于C型尼曼-匹克病1型的游离DNA筛查:病例系列
Front Med (Lausanne). 2024 Aug 5;11:1390693. doi: 10.3389/fmed.2024.1390693. eCollection 2024.
5
Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development Study.面向消费者的基因检测服务政策指南:框架开发研究
J Med Internet Res. 2024 Jul 17;26:e47389. doi: 10.2196/47389.
6
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions.无创产前检测(NIPT):可靠性、挑战与未来方向。
Diagnostics (Basel). 2023 Aug 2;13(15):2570. doi: 10.3390/diagnostics13152570.
7
Attitudes toward Medical Ethics among Obstetricians and Gynecologists in Saudi Arabia: An Exploratory Survey.沙特阿拉伯妇产科医生对医学伦理的态度:一项探索性调查。
Healthcare (Basel). 2023 May 11;11(10):1394. doi: 10.3390/healthcare11101394.
8
Cell-Free Fetal DNA and Non-Invasive Prenatal Diagnosis of Chromosomopathies and Pediatric Monogenic Diseases: A Critical Appraisal and Medicolegal Remarks.游离胎儿DNA与染色体病及儿科单基因疾病的无创产前诊断:批判性评估与法医学评论
J Pers Med. 2022 Dec 20;13(1):1. doi: 10.3390/jpm13010001.
9
Risk Assessment of the Increased Occurrence of Congenital Cardiac and Non-Cardiac Defects in Fetuses with a Normal Karyotype after Assisted Fertilization in Comparison to Natural Fertilization Based on Ultrasound Diagnostics.基于超声诊断对辅助生殖后核型正常胎儿与自然受孕胎儿相比先天性心脏和非心脏缺陷发生率增加的风险评估
J Clin Med. 2021 Nov 29;10(23):5630. doi: 10.3390/jcm10235630.
10
Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study).大阪胎儿游离DNA分析的滚环复制及成像技术临床验证(CRITO研究)
Diagnostics (Basel). 2021 Oct 4;11(10):1837. doi: 10.3390/diagnostics11101837.

本文引用的文献

1
Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers.Y RNA:其作为人类癌症潜在生物标志物和分子靶点的作用概述
Cancers (Basel). 2020 May 14;12(5):1238. doi: 10.3390/cancers12051238.
2
Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation.当前在欧洲、澳大利亚和美国使用的非侵入性产前检测:图形展示。
Acta Obstet Gynecol Scand. 2020 Jun;99(6):722-730. doi: 10.1111/aogs.13841. Epub 2020 Apr 3.
3
Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.非侵入性产前检测引入的伦理挑战:来自黎巴嫩和魁北克的医疗保健专业人员观点的定性研究。
BMC Med Ethics. 2020 Feb 10;21(1):15. doi: 10.1186/s12910-020-0455-x.
4
Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing.基于游离信使 RNA 测序的人类骨髓刺激和重建的无创特征分析。
Nat Commun. 2020 Jan 21;11(1):400. doi: 10.1038/s41467-019-14253-4.
5
An ethical framework for genetic counseling in the genomic era.基因组时代的遗传咨询伦理框架。
J Genet Couns. 2020 Oct;29(5):718-727. doi: 10.1002/jgc4.1207. Epub 2019 Dec 19.
6
Cell-free nucleic acids in prenatal diagnosis and pregnancy-associated diseases.游离核酸在产前诊断及妊娠相关疾病中的应用
EJIFCC. 2019 Jun 24;30(2):215-223. eCollection 2019 Jun.
7
Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples.罕见的常染色体三体:通过游离 DNA 分析和直接绒毛膜取样染色体制备检测的比较。
Ultrasound Obstet Gynecol. 2019 Oct;54(4):458-467. doi: 10.1002/uog.20383. Epub 2019 Sep 3.
8
Mothers of a child with Down syndrome: A qualitative analysis of the perspectives on non-invasive prenatal testing.唐氏综合征患儿的母亲:对非侵入性产前检测的观点的定性分析。
Midwifery. 2019 Sep;76:118-124. doi: 10.1016/j.midw.2019.06.001. Epub 2019 Jun 4.
9
Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.促进非侵入性产前检测(NIPT)知情选择:对女性体验的系统评价和定性元分析。
BMC Pregnancy Childbirth. 2019 Jan 14;19(1):27. doi: 10.1186/s12884-018-2168-4.
10
Looking into the shadow: the eugenics argument in debates on reproductive technologies and practices.审视阴影:生殖技术与实践辩论中的优生学观点
Monash Bioeth Rev. 2018 Dec;36(1-4):1-22. doi: 10.1007/s40592-018-0086-x.

与非侵入性产前检测相关的伦理、法律和社会问题(ELSI):对产前诊断和生殖选择演变的思考。

Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.

机构信息

Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Molecular Diagnosis and Characterization of Pathogenic Mechanisms of Rare Genetic Diseases, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.

出版信息

Genes (Basel). 2021 Jan 30;12(2):204. doi: 10.3390/genes12020204.

DOI:10.3390/genes12020204
PMID:33573312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7911180/
Abstract

New technologies such as non-invasive prenatal testing (NIPT), capable of analyzing cell-free fetal DNA in the maternal bloodstream, have become increasingly widespread and available, which has in turn led to ethical and policy challenges that need addressing. NIPT is not yet a diagnostic tool, but can still provide information about fetal genetic characteristics (including sex) very early in pregnancy, and there is no denying that it offers valuable opportunities for pregnant women, particularly those at high risk of having a child with severe genetic disorders or seeking an alternative to invasive prenatal testing. Nonetheless, the ethical, legal and social implications (ELSI) include multiple aspects of informed decision-making, which can entail risks for the individual right to procreative autonomy, in addition to the potential threats posed by sex-selective termination of pregnancy (in light of the information about fetal sex within the first trimester), and the stigmatization and discrimination of disabled individuals. After taking such daunting challenges into account and addressing NIPT-related medicolegal complexities, the review's authors highlight the need for an ethically and legally sustainable framework for the implementation of NIPT, which seems poised to become a diagnostic tool, as its scope is likely to broaden in the near future.

摘要

新技术如非侵入性产前检测(NIPT),能够分析母体血液中的游离胎儿 DNA,已经越来越普及,这也带来了需要解决的伦理和政策挑战。NIPT 目前还不是一种诊断工具,但仍然可以在怀孕早期提供有关胎儿遗传特征(包括性别)的信息,而且不可否认,它为孕妇提供了宝贵的机会,特别是那些有生育严重遗传疾病孩子风险的孕妇,或者寻求替代侵入性产前检测的孕妇。然而,其伦理、法律和社会影响(ELSI)包括知情决策的多个方面,这可能会对个人的生殖自主权利带来风险,除此之外,还可能存在因胎儿性别信息而导致的妊娠选择性终止(在孕早期)的威胁,以及对残疾个体的污名化和歧视。在考虑到这些令人望而生畏的挑战并解决与 NIPT 相关的医学法律复杂性之后,审查的作者强调了需要为 NIPT 的实施建立一个在伦理和法律上可持续的框架,因为 NIPT 似乎即将成为一种诊断工具,因为它的范围可能在不久的将来扩大。